COVID-19 follow-up programmes across Europe: an ERS END-COVID CRC survey. Issue 3 (15th September 2022)

• Record Type: Journal Article
• Authors: Valenzuela, Claudia; Nigro, Mattia; Chalmers, James D.; Wagers, Scott; Aujayeb, Avinash; Hellemons, Merel E.; Löffler-Ragg, Judith; Brightling, Christopher E.; Aliberti, Stefano
• Is Part Of: European respiratory journal. Volume 60:Issue 3(2022)
• Publication Date: 2022-09-15
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.00923-2022
• Languages: English
• ISSNs: 0903-1936

Abstract

SARS-CoV-2 is responsible for a multi-organ syndrome that can last over 12 months after the initial infection, which includes pulmonary and systemic consequences with residual radiological or functional alterations [1–3]. According to international guidelines, post-COVID-19 syndrome or condition is defined by a variety of signs and symptoms occurring during or after an infection consistent with COVID-19, lasting for more than 8–12 weeks and not explained by an alternative diagnosis [4, 5]. Main symptoms are fatigue, dyspnoea, arthralgia, chest pain, cough and neurocognitive impairment [6]. A large heterogeneity in the management of post-COVID-19 syndrome and in standard operating procedures for COVID-19 follow-up programmes across Europe exists https://bit.ly/3OdPxgF